SOD1 and amyotrophic lateral sclerosis: In a murine model of amyotrophic lateral sclerosis (ALS), a short treatment with clemastine (from postnatal day 40 to day 120) could delay the disease onset and extend the survival of SOD1-G93A mice by ~10% (Apolloni et al., 2016).